Sleep Health, Inflammation, and Emotion Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Depression
Interventions
BIOLOGICAL

Endotoxin

Low dose endotoxin (0.8 ng/kg of body weight) as IV bolus

BEHAVIORAL

Partial sleep deprivation

Partial night sleep deprivation by staying awake from 23:00 to 03:00

OTHER

Placebo

0.9% saline as IV bolus

OTHER

Uninterrupted sleep

Uninterrupted sleep from 23:00 to 07:00

Trial Locations (1)

90095

UCLA Cousins Center for Psychoneuroimmunology, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT02270619 - Sleep Health, Inflammation, and Emotion Study | Biotech Hunter | Biotech Hunter